Scarica l'app Stockscreener
1.05
13.93%
-0.17
Dopo l'orario di chiusura:
1.04
-0.01
-0.95%
Precedente Chiudi:
$1.22
Aprire:
$1.2
Volume 24 ore:
333.22K
Relative Volume:
3.08
Capitalizzazione di mercato:
$5.10M
Reddito:
-
Utile/perdita netta:
$-39.62M
Rapporto P/E:
-0.000635
EPS:
-1654.3275
Flusso di cassa netto:
$-17.96M
1 W Prestazione:
-39.13%
1M Prestazione:
-66.45%
6M Prestazione:
-97.45%
1 anno Prestazione:
-99.87%
Intervallo 1D:
$0.99
$1.2761
Intervallo di 1 settimana:
$0.99
$1.75
Portata 52W:
$0.99
$878.00
Cdt Equity Inc Stock (CDT) Company Profile
Nome
Cdt Equity Inc
Settore
Industria
Telefono
(646) 491 9132
Indirizzo
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
1.05 | 5.93M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc Borsa (CDT) Ultime notizie
Nirland-controlled group reports 75,315 CDT shares (NASDAQ: CDT) - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market SessionAIM ImmunoTech (AMEX:AIM), Atlantic Inter - Benzinga
CDT Equity Flags Delay in Quarterly Filing - TipRanks
CDT Equity Modifies Financing Agreements to Boost Liquidity - TipRanks
CDT Equity (NASDAQ: CDT) notifies SEC of delayed Q1 2026 10-Q; plans filing - Stock Titan
Cdt Equity Inc enters amendment no. 2 to equity line of credit facility on May 15, 2026SEC filing - marketscreener.com
CDT Equity Inc. (NASDAQ: CDT) tweaks equity line and note proceeds - Stock Titan
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
Corvus updates CDT Equity (CDT) ownership to about a 5.4% stake - Stock Titan
CEO-linked entities of CDT Equity (CDT) add shares, exercise warrants - Stock Titan
Number of shareholders of CDT Equity Inc. – NASDAQ:CDT - TradingView
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage - Yahoo Finance
CDT SEC FilingsCDT Equity 10-K, 10-Q, 8-K Forms - Stock Titan
CDT Equity Inc shares plunge 7.96% as Q1 2026 shows zero revenue and massive loss.EBIT Margin - Newser
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - The Manila Times
A patent filed in under 3 weeks puts CDT's Sarborg stake in focus - Stock Titan
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - AI Magazine
After 181-subject safety studies, CDT seeks partner for infertility drug - Stock Titan
CDT Equity Inc. Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - marketscreener.com
[EFFECT] CDT Equity Inc. SEC Filing - Stock Titan
5.35M CDT Equity (NASDAQ: CDT) shares registered for resale by selling holders - Stock Titan
CDT Equity (CDT) director discloses 233,585 Common Stock shares on Form 3 - Stock Titan
CDT - Finviz
CDTTW (CDT Warrant) leadership outlines long-term growth priorities as latest quarterly earnings figures remain undisclosed.Recovery Report - newser.com
CDT Equity Announces Board Changes and New Chairperson - The Globe and Mail
CDT Equity announces reverse stock split - MSN
Board reshuffle at CDT Equity (NASDAQ: CDT) adds Ulrik Olsen, new chairs - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Conduit to change name to CDT Equity - MSN
Stock List: Research Stocks from Around the World - GuruFocus
Working capital per share of CDT Equity Inc. – FWB:ZK7 - TradingView
EBITDA per share of CDT Equity Inc. – FWB:ZK7 - TradingView
CDT Equityfiles for offering of up to 5.35 million shares of common stockSEC filing - marketscreener.com
CDT Equity (NASDAQ: CDT) registers 5.35M shares; ELOC and Sarborg issuances - Stock Titan
Equity Inc (CDT) Stock: Is It Reasonably Valued (Dips) 2026-04-20Elite Trading Signals - Xã Thanh Hà
CDT Notes Sarborg Publication of PRISM Framework Expanding AI - 富途牛牛
Prospect Capital Securities Ltd Net Worth (2026) - GuruFocus
Prospect Finance Ltd Net Worth (2026) - GuruFocus
Mark Andrew Taylor Net Worth (2026) - GuruFocus
Keep an eye on the top gainers and losers in Thursday's session. - ChartMill
AstraZeneca (AZN) Advances Portfolio with Strategic Update - GuruFocus
CDT Equity expands multi-pathway value creation strategy across pharma, IP - TipRanks
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery - The Manila Times
Tiny Nasdaq biotech links AstraZeneca assets with AI drug hunting - Stock Titan
CDT Equity Inc. 2025 Annual Report: Nasdaq Listing, Reverse Stock Splits, and Financial Highlights (CDT, CDTTW) - Minichart
Cdt Equity Inc Azioni (CDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):